نتایج جستجو برای: oxybutynin

تعداد نتایج: 381  

Journal: :Nucleic acids research 1977
J Lebowitz A K Chaudhuri A Gonenne G Kitos

Superhelical PM2 DNA I can be modified with N-cyclohexyl-N'-beta-(4-methylmorpholinium)ethyl carbodiimide (CMC). The transition of the sedimentation coefficient uncorrected for buoyant density change (S20,*) vs. % reactivity in terms of base pairs shows the following characteristics. The S20,* increases by 4.5 S units upon 1% modification. There is a plateau in S20,* between 1 and 4% reactivity...

Journal: :Molecules 2015
Tiago Fernandes da Silva Walfrido Bispo Júnior Magna Suzana Alexandre-Moreira Fanny Nascimento Costa Carlos Eduardo da Silva Monteiro Fabio Furlan Ferreira Regina Cely Rodrigues Barroso François Noël Roberto Takashi Sudo Gisele Zapata-Sudo Lídia Moreira Lima Eliezer J Barreiro

The N-acylhydrazone (NAH) moiety is considered a privileged structure, being present in many compounds with diverse pharmacological activities. Among the activities attributed to NAH derivatives anti-inflammatory and analgesic ones are recurrent. As part of a research program aiming at the design of new analgesic and anti-inflammatory lead-candidates, a series of cyclohexyl-N-acylhydrazones 10-...

Journal: :Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 2010
Marwa S El Hamshary Omar H Salem Rasha M El Nashar

Two ion-selective sensors of the plastic membrane type were prepared for the determination of oxybutynin hydrochloride (OxCl). They depend on the incorporation of the ion-associates with phosphotungestic acid or phosphomolybdic acid in a PVC matrix. A comparative study is made between their performance characteristics in batch and FIA conditions. The sensors have nearly the same usable concentr...

Journal: :The Journal of Urology 2021

You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Non-neurogenic Voiding Dysfunction I (MP02)1 Sep 2021MP02-14 AN EVALUATION OF THE FEDERAL ADVERSE EVENTS REPORTING SYSTEM DATA ON EFFECTS OVERACTIVE BLADDER MEDICATIONS Siri Drangsholt, Michelina Stoddard, Stephanie Sansone, Ahra Cho, and Bilal Chughtai DrangsholtSiri Drangsholt More articles by...

2014
Jung Hoon Lee Kyoung Rok Kim Yong Seung Lee Sang Won Han Kun Suk Kim Sang Hoon Song Minki Baek Kwanjin Park

PURPOSE Anticholinergics are a key element in treating neurogenic detrusor overactivity, but only limited data are available in the pediatric population, thus limiting the application to children even for oxybutynin chloride (OC), a prototype drug. This retrospective study was designed to provide data regarding the efficacy, tolerability, and safety of OC in the pediatric population (0-15 years...

Journal: :Clinical Interventions in Aging 2007
Sum Lam Olga Hilas

Overactive bladder (OAB) is a prevalent and costly condition that can affect any age group. Typical symptoms include urinary urgency, frequency, incontinence and nocturia. OAB occurs as a result of abnormal contractions of the bladder detrusor muscle caused by the stimulation of certain muscarinic receptors. Therefore, antimuscarinic agents have long been considered the mainstay of pharmacologi...

2006
Ryan Roberts

Volume 22, Issue 2 November 2006 1 Overactive bladder (OAB) is a chronic and potentially debilitating condition that affects approximately 16% of the adult population in the U.S. and Europe. According to the National Overactive Bladder Evaluation (NOBLE) program, an estimated 34 million Americans have symptoms of OAB. Overactive bladder is a common condition in both men and women of all ages, b...

Journal: :Journal of Drug Metabolism & Toxicology 2018

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید